This inventor holds 5 USPTO granted patents and 1 published patent application, plus 2 CIPO patents and 2 EPO patents. Top assignees: Sato Pharmaceutical Co., Ltd., Sato Pharmaceutical Co., Ltd.. Active years: 2015-2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Kawasaki, JP (2015 - 2016)
- Tokyo, JP (2016 - 2017)
Company Filing History:
Years Active: 2015-2026
Title: Motoaki Baba - Innovator in Pharmaceutical Chemistry
Introduction
Motoaki Baba is a prominent inventor based in Tokyo, Japan. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of compounds that have therapeutic applications. With a total of four patents to his name, Baba's work is recognized for its potential impact on health and medicine.
Latest Patents
One of Baba's latest patents involves a difluoromethylene compound that exhibits URAT1 inhibitory activity. This compound serves as an URAT1 inhibitor, a blood uric acid level-reducing agent, and is part of a pharmaceutical composition. The invention specifically relates to a compound represented by a particular formula, which highlights its innovative approach to addressing health issues related to uric acid levels.
Career Highlights
Baba is currently associated with Sato Pharmaceutical Co., Ltd., where he continues to advance his research and development efforts. His work is characterized by a commitment to creating effective pharmaceutical solutions that can improve patient outcomes.
Collaborations
Throughout his career, Baba has collaborated with notable colleagues, including Keita Nagai and Koh Nagasawa. These partnerships have contributed to the successful development of his innovative compounds and have fostered a collaborative environment for research.
Conclusion
Motoaki Baba is a distinguished inventor whose work in pharmaceutical chemistry is paving the way for new treatments. His innovative compounds and collaborative efforts reflect his dedication to improving health outcomes through scientific advancement.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile